.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Covington
Dow
UBS
Baxter
Federal Trade Commission
Chinese Patent Office
McKesson
Deloitte
Argus Health

Generated: November 24, 2017

DrugPatentWatch Database Preview

AMINOSYN 3.5% M IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

Which patents cover Aminosyn 3.5% M In Plastic Container, and when can generic versions of Aminosyn 3.5% M In Plastic Container launch?

Aminosyn 3.5% M In Plastic Container is a drug marketed by Abbott and is included in two NDAs.

The generic ingredient in AMINOSYN 3.5% M IN PLASTIC CONTAINER is amino acids; magnesium acetate; phosphoric acid; potassium acetate; sodium chloride. There are three hundred and forty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amino acids; magnesium acetate; phosphoric acid; potassium acetate; sodium chloride profile page.

Summary for AMINOSYN 3.5% M IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott
AMINOSYN 3.5% M IN PLASTIC CONTAINER
amino acids; magnesium acetate; phosphoric acid; potassium acetate; sodium chloride
INJECTABLE;INJECTION018804-002May 15, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
AMINOSYN 3.5% M IN PLASTIC CONTAINER
amino acids; magnesium acetate; phosphoric acid; potassium acetate; sodium chloride
INJECTABLE;INJECTION018875-002Aug 8, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
UBS
Cerilliant
Johnson and Johnson
Queensland Health
AstraZeneca
Cantor Fitzgerald
Chinese Patent Office
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot